Cargando…

The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype: Results from the TODAY study

OBJECTIVE: To determine the frequency of islet cell autoimmunity in youth clinically diagnosed with type 2 diabetes and describe associated clinical and laboratory findings. RESEARCH DESIGN AND METHODS: Children (10–17 years) diagnosed with type 2 diabetes were screened for participation in the Trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klingensmith, Georgeanna J., Pyle, Laura, Arslanian, Silva, Copeland, Kenneth C., Cuttler, Leona, Kaufman, Francine, Laffel, Lori, Marcovina, Santica, Tollefsen, Sherida E., Weinstock, Ruth S., Linder, Barbara
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928346/ https://www.ncbi.nlm.nih.gov/pubmed/20519658 http://dx.doi.org/10.2337/dc10-0373

Ejemplares similares

ZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition index
por: Higgins, Janine, et al.
Publicado: (2022)

Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience
por: Klingensmith, Georgeanna J., et al.
Publicado: (2016)

Monogenic Diabetes in Overweight and Obese Youth Diagnosed with Type 2 Diabetes: The TODAY Clinical Trial
por: Kleinberger, Jeffrey W., et al.
Publicado: (2017)

Insulin Regimens and Clinical Outcomes in a Type 1 Diabetes Cohort: The SEARCH for Diabetes in Youth study
por: Pihoker, Catherine, et al.
Publicado: (2013)

Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
por: Badaru, Angela, et al.
Publicado: (2014)

Impact of GAD65 and IA2 autoantibodies on islet allograft survival
por: Lemos, Joana R. N., et al.
Publicado: (2023)

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
por: Burbelo, Peter D., et al.
Publicado: (2010)

Crisis in Care: Limited Treatment Options for Type 2 Diabetes in Adolescents and Youth
por: Tamborlane, William V., et al.
Publicado: (2013)

Etiological Approach to Characterization of Diabetes Type: The SEARCH for Diabetes in Youth Study
por: Dabelea, Dana, et al.
Publicado: (2011)

ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
por: Delic-Sarac, Marina, et al.
Publicado: (2016)

Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients
por: Chuzho, Neihenuo, et al.
Publicado: (2021)

Depressive Symptoms and Quality of Life in Adolescents With Type 2 Diabetes: Baseline data from the TODAY study
por: Anderson, Barbara J., et al.
Publicado: (2011)

Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct
por: Howson, Joanna M.M., et al.
Publicado: (2011)

Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
por: Kanner, Lauren, et al.
Publicado: (2019)

Interaction of Onset and Duration of Diabetes on the Percent of GAD and IA-2 Antibody–Positive Subjects in the Type 1 Diabetes Genetics Consortium Database
por: Tridgell, David M., et al.
Publicado: (2011)

Research of anti-GAD and anti-IA2 autoantibodies by ELISA test in a series of Moroccan pediatric patients with diabetes type 1
por: Belhiba, O, et al.
Publicado: (2020)

Physical Activity in Adolescent Females with Type 1 Diabetes
por: Schweiger, Bahareh, et al.
Publicado: (2010)

Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
por: Pörksen, Sven, et al.
Publicado: (2010)

The Psychometric Properties and Clinical Utility of the Korean Version of GAD-7 and GAD-2
por: Ahn, Jung-Kwang, et al.
Publicado: (2019)

Good MRI images: to Gad or not to Gad?
por: Steen, Henning, et al.
Publicado: (2007)

Menarchal Timing in Type 1 Diabetes Through the Last 4 Decades
por: Schweiger, Bahareh, et al.
Publicado: (2010)

Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a Primary Care Setting
por: Sapra, Amit, et al.
Publicado: (2020)

Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine
por: Seo, Jong-Geun, et al.
Publicado: (2015)

Team Clinic: Group Approach to Care of Early Adolescents With Type 1 Diabetes
por: McClain, Megan Rose, et al.
Publicado: (2018)

Skin and Psychosomatics – Psychodermatology today
por: Gieler, Uwe, et al.
Publicado: (2020)

Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
por: Vrublevska, Jelena, et al.
Publicado: (2022)

Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young
por: Steck, Andrea K., et al.
Publicado: (2011)

No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
por: Thorsen, Steffen U., et al.
Publicado: (2016)

GAD2 Identified as Candidate Gene for Obesity
Publicado: (2003)

Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4
por: Lampasona, Vito, et al.
Publicado: (2010)

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)

Insights: fear of GAD
por: Wright, Duncan
Publicado: (2021)

Genome-wide identification of GAD family genes suggests GhGAD6 functionally respond to Cd(2+) stress in cotton
por: Huang, Hui, et al.
Publicado: (2022)

International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B
por: Marcovina, Santica, et al.
Publicado: (1990)

GADS escala Gilliam para evaluar trastorno de Asperger
por: Gilliam, James E.
Publicado: (2008)

The TODAY Study: An NIH Perspective on Its Implications for Research
por: Linder, Barbara L., et al.
Publicado: (2013)

Expression of GAD67 and Novel GAD67 Splice Variants During Human Fetal Pancreas Development: GAD67 Expression in the Fetal Pancreas
por: Korpershoek, Esther, et al.
Publicado: (2007)

Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes
por: Schweiger, Bahareh M, et al.
Publicado: (2011)

Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes
por: Steck, Andrea K., et al.
Publicado: (2014)

The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials
por: Thalange, Nandu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3dsole8l3a7fh513o0vh31sp9